Corsano Health
  • Solutions
    • Remote Monitoring
    • In-Hospital Monitoring
    • Pharma
    • Research
    • Education
  • Use Cases
    • Arrhythmias
    • Hypertension
    • Clinical Deterioration
    • Cardiac Arrest
    • Mental Health
  • System
    • CardioWatch 287
    • Vital Parameters
    • Data Access
    • System status
    • FAQ
  • Resources
    • Publications
    • Clinical Trials
    • White Papers
    • News
    • Insights
  • Company
    • About Us
    • Team
    • Medical Board
    • Careers
    • Compliance
    • Intranet
  • Support
  • Contact Us
Select Page
Realtime monitoring of activity and feedback for patients with femoral bone metastases

Realtime monitoring of activity and feedback for patients with femoral bone metastases

by Matthias Burel | Nov 8, 2023 | Clinical Trials

TopicBone metastases represent a common complication in cancer patients, particularly in advanced stages of the disease. The presence of bone metastases can cause skeletal-related events, such as bone pain, pathological fractures, spinal cord compression, and...
Safety and efficacy of anti-CD19 CAR T in subjects with Lymphocytic Lymphoma

Safety and efficacy of anti-CD19 CAR T in subjects with Lymphocytic Lymphoma

by Matthias Burel | Nov 8, 2023 | Clinical Trials

TitleA study evaluating the safety and efficacy of anti-CD19 CAR T in subjects with Lymphocytic Lymphoma. TopicA phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured 19CP02 in subjects with relapsed/refractory...
Corsano EndoWatch; the smart device that helps patients with hormonal imbalance after treatment for a brain tumor.

Corsano EndoWatch; the smart device that helps patients with hormonal imbalance after treatment for a brain tumor.

by Matthias Burel | Jan 7, 2022 | News

Corsano EndoWatch; the smart device that helps patients with hormonal imbalance after treatment for a brain tumor. Research Summary Children and adolescents with hypothalamic brain tumors often have excellent survival, but poor outcome due to hypothalamic dysfunction...

News

  • Corsano Health Wins Call Heart Foundation
  • Cardiac Surveillance in the Digital Age
  • Innovative Horizons in Hypertension Monitoring: Corsano’s CardioWatch 287-2 System
  • Corsano CardioWatch Impact Framework
  • Certified Software

Continuous Cardiac Monitoring
Anytime, Anywhere

Research

Patient Care

System

Resources

Company

Contact Us

Terms

Privacy

Security

GDPR

DPO

  • LinkedIn
  • Youtube
© 2025 Corsano Health - All rights reserved